Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies. 2013

Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
Department of Orthopedics Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

BACKGROUND The association between polymorphisms on 5p12 and breast cancer (BC) has been widely evaluated since it was first identified through genome-wide association approach; however, the studies have yielded contradictory results. We sought to investigate this inconsistency by performing a comprehensive meta-analysis on two wildly studied polymorphisms (rs10941679 and rs4415084) on 5p12. METHODS Databases including Pubmed, EMBASE, Web of Science, EBSCO, and Cochrane Library databases were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. The random-effects model was applied, addressing heterogeneity and publication bias. RESULTS A total of 19 articles involving 100,083 cases and 163,894 controls were included. An overall random-effects per-allele OR of 1.09 (95% CI: 1.06-1.12; P = 4.5 × 10(-8)) and 1.09 (95% CI: 1.05-1.12; P = 4.2 × 10(-7)) was found for the rs10941679 and rs4415084 polymorphism respectively. Significant results were found in Asians and Caucasians when stratified by ethnicity; whereas no significant associations were found among Africans/African-Americans. Similar results were also observed using dominant or recessive genetic models. In addition, we find both rs4415084 and rs10941679 conferred significantly greater risks of ER-positive breast cancer than of ER-negative tumors. CONCLUSIONS Our findings demonstrated that rs10941679-G allele and rs4415084-T allele might be risk-conferring factors for the development of breast cancer, especially in Caucasians and East-Asians.

UI MeSH Term Description Entries
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002895 Chromosomes, Human, Pair 5 One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5). Chromosome 5
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
May 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
October 2014, Molecular genetics and genomics : MGG,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
May 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
January 2013, PloS one,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
May 2019, Medicine,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
February 2015, Molecular biology reports,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
August 2017, Medicine,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
March 1991, International journal of cancer,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
August 2017, World journal of surgical oncology,
Xiaofeng Wang, and Liang Zhang, and Zixian Chen, and Yushui Ma, and Yuan Zhao, and Abudouaini Rewuti, and Feng Zhang, and Da Fu, and Yusong Han
January 2016, Journal of Cancer,
Copied contents to your clipboard!